Patent holdings for IPC class C07D 491/052

Total number of patents in this class: 1043

10-year publication summary

95
74
78
78
81
77
101
99
79
1
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Gilead Sciences, Inc.
1949
36
Bristol-myers Squibb Company
4886
22
Merck Sharp & Dohme LLC
3742
18
Merck Patent GmbH
5849
17
Novartis AG
11297
15
F. Hoffmann-La Roche AG
7942
14
Eli Lilly and Company
3718
14
Vertex Pharmaceuticals Incorporated
1570
13
Daiichi Sankyo Company, Limited
1863
13
Takeda Pharmaceutical Company Limited
2945
12
Boehringer Ingelheim International GmbH
4762
10
Arbutus Biopharma Corporation
189
10
Merck Sharp & Dohme Corp.
2218
9
Hoffmann-La Roche Inc.
3252
8
The Regents of the University of California
19479
8
Genentech, Inc.
3864
8
Emory University
1588
8
Kadmon Corporation, LLC
92
8
Vanderbilt University
1811
8
Glaxo Group Limited
4286
7
Other owners 785